Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Madrigal Pharmaceuticals
Biotech
John Cox gets new biotech CEO gig at Dyne—Chutes & Ladders
Cox named new CEO of Dyne. Ex-Madrigal US sales chief named CCO of Nuvation. Longtime NIAID leader leaves for CSO gig at Alphabet's Calico.
Max Bayer
,
Gabrielle Masson
Mar 29, 2024 9:30am
Chinese biotech's MASH drug reduces liver fat in phase 2 trial
Mar 18, 2024 11:07am
As Madrigal lands MASH nod, what's next for biotechs in pursuit?
Mar 15, 2024 10:55am
Ionis raises hand in MASH race, shows liver gains in ph. 2 test
Mar 13, 2024 9:54am
Hepion’s NASH trial hangs in balance amid cost-cutting, CEO exit
Dec 7, 2023 11:38am
FDA promotes Bumpus to replace Woodcock—Chutes & Ladders
Dec 1, 2023 9:48am